Expert Board Member

He has also helped support the development of entrepreneur businesses within the Bioscience Community.

International Boards

International Boards

National Institute of Cellular Biotechnology,Dublin City University, Dublin, Ireland. Kevin J. Scanlon is a member of the Scientific Advisory Board at the National Institute of Cellular Biotechnology (NICB) in Dublin, Ireland since 2000-2014. This is the first Biotechnology Center in Europe that integrates the pharmaceutical industry and the academic community with the strong financial support of the Irish government. The NICB has been an effective model for other European and Asian countries to emulate. The NICB is a multidisciplinary center of research in fundamental and applied Cellular Biotechnology, Molecular Cell Biology and Biological Chemistry. It includes a multidisciplinary team of Cell and Molecular Biologists, Biotechnologists. The institute draws from the established expertise of researchers in Dublin City University, IT Tallaght and NUI Maynooth with the aim to be a Center of world-class expertise, in Cellular and Molecular Biotechnology, in the discovery of novel molecules with Biological applications and in related areas including Bio-computing, Bio-ethics, and Science Communication.

The Faculty of Science and Health, Dublin City University, Dublin, Ireland
www.dcu.ie/science_and_health/ Kevin J. Scanlon is a member of the Faculty Advisory Board, Dublin City University since 2006-2014.

Molecular Therapeutics for Cancer Program for Ireland, Dublin, Ireland www.mtci.ie Kevin J. Scanlon is Vice Chairman of the Scientific Advisory Board on the Molecular Therapeutics for Cancer Program. He has been a member since 2009-2014.

Archport Ltd. provides contract production and R&D services (including animal cell fermentation and downstream processing) to the biopharmaceutical / biotechnology industry, specializing in recombinant proteins. The work is performed under ‘current Good Manufacturing Practice’ (cGMP) conditions at our production facility. Archport’s expertise ranges from cell culture and DSP process development, optimization and validation to QA and QC issues in cGMP environments. As well as conducting training/teaching courses in biopharmaceutical production. Archport has a state-of-the-art manufacturing facility, fully validated. (2001-2010)

Bridges to Italy, Rolling Hills Estates, CA 90274 (www.bridgestoitaly.org) Kevin J. Scanlon is a member of the advisory board for the Italian Government “Bridges to Italy”.

Advisory Boards - Domestic Boards

Kevin J. Scanlon is a member of the Presidential Advisory Board at the University of Southern California (2010-2014). Located in Los Angeles, a global center for arts, technology and international trade, the University of Southern California is one of the world’s leading private research universities. USC enrolls more international students than any other U.S. university and offers extensive opportunities for internships and study abroad. With a strong tradition of integrating liberal and professional education, USC fosters a vibrant culture of public service and encourages students to cross academic as well as geographic boundaries in their pursuit of knowledge.

Kevin J. Scanlon is a member of the Advisory Board for the Business Technology Center (BTC) of Los Angeles County (2004-2014). The BTC is the largest technology incubator in California. This Center is a business innovation center with a mission of assisting start-up and early stage technology firms grow and prosper. Opened in October 1998, the BTC is a 40,000 square foot facility with a state-of-the-art communication infrastructure. The BTC offers key support services, including access to capital, business consulting, and mentoring from an Advisory Committee that has a wide range of skills, experience and contacts in Southern California. It is located just 2 miles from the world famous Jet Propulsion Laboratory in Pasadena, the BTC currently houses 30 high technology tenants with specialties ranging from software development to commercializing federal lab technology. BTC firms have raised over $50 million from angel and venture capital investors

Kevin J. Scanlon is a member of the organizing committee for Los Angeles County Tech Week (2006-2014). Few places in the world can match the amount of technology growth and development than Los Angeles County. From entertainment to defense, from research labs to transportation and from software engineering to biotechnology, Los Angeles County is a “want-to-be” location for technology entrepreneurs. These entrepreneurs make technology happen and they become world class technology leaders. Los Angeles County Technology Week showcases to the community and to the world the many creative ideas and tremendous accomplishments of these amazing entrepreneurs. Tech Week also attracts capital, management talent, customers and key resources to support and advance the region’s vital technology economy.

Kevin J. Scanlon is a board observer for Numira Biosciences. Numira has established a reputation for cutting edge drug discovery and development technologies including software, reagents and small animal imaging services. With our expert laboratory staff, biomedical engineers, software developers, developmental biologists and board certified radiologists, we are pushing the boundaries of traditional drug discovery methods by delivering novel research capabilities and expert analysis to our diverse customer base of universities, pharmaceutical companies and CRO’s.

Kevin J. Scanlon is a member of the NEXTConnections Advisory Board at the BEALL Center for Art + Technology at the University of California, Irvine (2006-2010). The mission of the Beall Center is to support research and exhibitions that explore new relationships between the arts, sciences, and engineering, and thus, promote new forms of creation and expression using digital technologies. The Beall Center aspires to redefine the museum/gallery experience, both in content and form, formulating answers to the questions of how technology can be used effectively, not only to create new forms of art, but also to connect artist to artist, and artist with audience.

The California Breast Cancer Research Program (CBCRP) was established pursuant to passage by the California Legislature of the 1993 Breast Cancer Act 1993. The program is responsible for administering funding for breast cancer research in the State of California. The mission of the CBCRP is to eliminate breast cancer by leading innovation in research, communication, and collaboration in the California scientific and lay communities. The CBCRP is the largest state-funded research effort in the nation and is administered by the University of California, Office of the President. The CBCRP is funded through the tobacco tax, voluntary tax check-off on personal income tax forms, and individual contributions. The tax check-off, included on the personal income tax form since 1993, has drawn over $4 million for breast cancer research. Ninety-five percent of our revenue goes directly to funding research and education efforts. The revenue is used to make grants for California scientists and community researchers to find better ways to prevent, treat and cure breast cancer. (1997-1999)

Non-Profit Boards

Non-Profit Boards

Community First Initiatives, Svay Dankom Commune, Siem Reap Province, Kingdom of Cambodia www.cfi-asia.org Kevin J. Scanlon is a member of the Board of Directors since 2009-2014.The Community First Initiatives’ mission is to reduce the devastating effects of poverty by building bridges between people with financial, intellectual and other essential resources and those with needs. This would result in the creation of locally-based businesses that provide sustainable employment, ultimate ownership and other benefits for forgotten communities.

Expert Witness

I have been asked to provide opinions on investor fundraising for and financing of biotechnology start-ups in relation to provisions of license agreements. My knowledge and experience extends to the medical science of molecular biology and pharmacology, investor philosophy of supporting startup companies and the challenges of a CEO to do a new venture. I have written reports of legal cases and been deposed on my knowledge and legal report.

Let’s talk about your next big project.

Feel free to contact me by filling out this form or you can email me at info@kjscanlon.com

Kevin J. Scanlon, Ph.D.
Boston, MA 02123